|
1.
|
2026/08/15
|
|
Aspiration pneumonia with herpes simplex encephalitis in an elderly Japanese patient
|
|
2.
|
2026/08/10
|
|
Mixed diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with Aeromonas caviae bacteremia and Escherichia coli O125 detected in stool in an adult patient
|
|
3.
|
2026/08/07
|
|
A GLP-1 receptor agonist enhances islet microvascular flow through nitric oxide-dependent mechanisms in a diabetic mouse model: investigation using intravital two-photon imaging
|
|
4.
|
2026/08/03
|
|
Overlap syndrome between sarcoidosis and Sjögren's disease presenting as hypopituitarism: Case report and review of literature
|
|
5.
|
2026/07/19
|
|
Durability and safety of imeglimin as an add-on to DPP-4 inhibitors in Japanese type 2 diabetes: the 104-week FAMILIAR trial
|
|
6.
|
2026/07/01
|
|
C-peptide index under non-fasting conditions can predict the likelihood of future insulin therapy in outpatients with diabetes mellitus not receiving insulin at baseline
|
|
7.
|
2026/06/27
|
|
Association between grip strength and the diabetes complications severity index (DCSI) in patients with type 2 diabetes mellitus
|
|
8.
|
2026/06/01
|
|
Association between phase angle and HbA1c in non-elderly patients with type 2 diabetes mellitus: A cross-sectional study using outpatient clinical data
|
|
9.
|
2026/05/01
|
|
123I-MIBG scintigraphy-negative pheochromocytoma without hypertension found during follow-up for non-functioning adrenal incidentaloma
|
|
10.
|
2026/04/07
|
|
A case of autoimmune polyendocrine syndrome type 3 with warm type autoimmune hemolytic anemia developed during treatment for Hashimoto's thyroiditis
|
|
11.
|
2026/04/07
|
|
Early intervention with tirzepatide or semaglutide influences anti-atherosclerotic effects in ApoE knockout mice.
|
|
12.
|
2026/04/05
|
|
Clinical impact of a rapid-acting insulin bolus at the initiation of continuous insulin infusion therapy in patients with hyperglycemic crisis: a propensity score-matched analysis
|
|
13.
|
2026/04
|
|
Effect of metformin dose reduction versus continuation at imeglimin initiation on glycemic control in type 2 diabetes: a retrospective real-world analysis
|
|
14.
|
2026/03/01
|
|
Diabetic Ketoacidosis Associated with Non-occlusive Mesenteric Ischemia in a Subject with Type 2 Diabetes Mellitus: A Case Report
|
|
15.
|
2026/02
|
|
Correlation between diabetes complications severity index and actual complication severity and diabetic medication in Japanese patients with type 2 diabetes mellitus
|
|
16.
|
2026/01
|
|
Assay-specific machine-learning models converting insulin to C-peptide or C-peptide index and C-peptide to HOMA2-IR: Single-center retrospective observational study
|
|
17.
|
2026
|
|
A case of influenza-associated parotitis in a Japanese adolescent.
|
|
18.
|
2026
|
|
Glucocorticoids directly inhibit insulin biosynthesis via the glucocorticoid receptor in pancreatic β-cells
|
|
19.
|
2026
|
|
Hypertensive urgency caused by postoperative glucocorticoid replacement therapy for Cushing's disease: A case report
|
|
20.
|
2026
|
|
Impact of patient body composition and handgrip strength on glycemic management of type 2 diabetes: Cross-sectional study based on outpatient clinical data in Japan
|
|
21.
|
2026
|
|
Indicators for predicting continuous insulin infusion therapy-related hypokalemia: Multicenter retrospective cohort study
|
|
22.
|
2025/12/01
|
|
A case of Haily-Haily disease accompanied by Cushing's syndrome and adrenal insufficiency due to long-term usage of topical steroids.
|
|
23.
|
2025/10/02
|
|
Molecular mechanism for pancreatic β-cell dysfunction and atherosclerosis and its therapeutic application: Importance of translational research bridging clinical practice and basic research
|
|
24.
|
2025/06/28
|
|
A clinical model for highly accurate prediction of blood glucose depression after continuous intravenous insulin therapy in hyperglycemic emergencies: A multicenter retrospective cohort study.
|
|
25.
|
2025/06/11
|
|
Rhabdomyolysis triggered by initiation of tirzepatide: A case report
|
|
26.
|
2025/06/03
|
|
Development of a prediction model by combining tumor diameter and clinical parameters of adrenal incidentaloma
|
|
27.
|
2025/06
|
|
Efficacy and safety of imeglimin add-on to DPP-4 inhibitor therapy in Japanese patients with type 2 diabetes mellitus: An interim analysis of the randomised, double-blind FAMILIAR trial
|
|
28.
|
2025/05/23
|
|
Clinical characteristics of patients with hyperglycemic hyperosmolar state and/or diabetic ketoacidosis: single-center retrospective observational study.
|
|
29.
|
2025/04/01
|
|
Handgrip strength in patients with type 2 diabetes correlates with diabetic polyneuropathy. A single-center, retrospective observational study in Japanese patients.
|
|
30.
|
2025/03/29
|
|
Blocking mineralocorticoid signaling with esaxerenone reduces atherosclerosis in hyperglycemic ApoE KO mice without affecting blood pressure and glycolipid metabolism
|
|
31.
|
2025/03
|
|
Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid Leukemia.
|
|
32.
|
2025/01
|
|
Clinical outcomes of immune checkpoint inhibitor-induced endocrine and other disorders in Japanese patients
|
|
33.
|
2025
|
|
Evaluation of short-term knowledge change through a diabetes education program at Kawasaki Medical School Hospital
|
|
34.
|
2024/12
|
|
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β-cells and hepatic steatosis in obese type 2 diabetic db/db mice.
|
|
35.
|
2024/11
|
|
Insulin administration to an abdominal insulin ball that triggered the onset of diabetic ketoacidosis accompanied by Hamman’s syndrome in a patient with type 1 diabetes mellitus
|
|
36.
|
2024/10/26
|
|
Effectiveness of switching from dipeptidyl peptidase-4 inhibitor to oral glucagon-like peptide-1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matching
|
|
37.
|
2024/10/21
|
|
Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study)
|
|
38.
|
2024/10/17
|
|
Comparison of Magnetic Resonance Imaging Features Between Programmed Cell Death 1/Programmed Cell Death Ligand 1 Inhibitor-Induced Hypopituitarism and Idiopathic Hypopituitarism in Japanese Subjects
|
|
39.
|
2024/10
|
|
A case of Sheehan syndrome with early postpartum panhypopituitarism and long-term partial improvement of endocrine function
|
|
40.
|
2024/09
|
|
Morphological Differences in the Abdominal Aorta Between Subjects With and Without Type 2 Diabetes
|
|
41.
|
2024/07
|
|
C-peptide index at 2 hour after meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes
|
|
42.
|
2024/07
|
|
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus
|
|
43.
|
2024/06
|
|
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice
|
|
44.
|
2024/06
|
|
The Impact of Hand Strength on HbA1c, Body Mass Index and Body Composition by Group According to Sedentary Behaviour: Cross-Sectional Study in Japanese Patients with Type 2 Diabetes Mellitus
|
|
45.
|
2024/05/23
|
|
Clinical findings of acute necrotizing esophagitis complicated by diabetic ketoacidosis
|
|
46.
|
2024/04
|
|
The impact of grip strength, waist circumference, and body mass index on Hemoglobin A(1c) value: Cross-sectional study using outpatient clinical data in Japanese elderly patients with type 2 diabetes mellitus
|
|
47.
|
2024/03/19
|
|
Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ
|
|
48.
|
2024/03/08
|
|
A case of Empty Sella syndrome with adrenal insufficiency masked by prednisolone after administration of immune checkpoint inhibitors
|
|
49.
|
2024/01/04
|
|
Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study
|
|
50.
|
2023/12
|
|
Comparison of clinical efficacy and safety of weekly glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel-group, multicentre, open-label trial (COMING study)
|
|
51.
|
2023/09/20
|
|
Structural and functional differences in auto-antibody positive compared to auto-antibody negative hypothyroid patients with chronic thyroiditis
|
|
52.
|
2023/09/09
|
|
Comprehensive Search for GPCR Compounds which Can Enhance MafA and/or PDX-1 Expression Levels Using a Small Molecule Compound Library
|
|
53.
|
2023/08/17
|
|
Simple standing test without furosemide is useful in the diagnosis of primary aldosteronism
|
|
54.
|
2023/07/31
|
|
Immune checkpoint inhibitor-induced hypothyroidism predicts treatment response in Japanese subjects
|
|
55.
|
2023/07
|
|
Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study
|
|
56.
|
2023/03/15
|
|
Influence of Nutritional Guidance/Consulting on Glycemic Control during the Coronavirus Disease 2019 Pandemic in Patients with Type 2 Diabetes Mellitus
|
|
57.
|
2023/01/30
|
|
A Male Subject with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Which Was Diagnosed at 31 Years Old due to Infertility
|
|
58.
|
2023/01/23
|
|
Incidence of endocrine-related immune-related adverse events in Japanese subjects with various types of cancer
|
|
59.
|
2022/12/16
|
|
Case report of severe hypoglycemic alcoholic ketoacidosis: A possible pitfall in diagnosis of ketoacidosis
|
|
60.
|
2022/12/01
|
|
A Case of Central Diabetes Insipidus due to Igg4-related Hypophysitis that Required Over One Year to Reach the Final Diagnosis due to Symptoms Being Masked by Sialadenitis
|
|
61.
|
2022/10/27
|
|
Correlation of Baba's diabetic neuropathy classification with various diabetes-related complications
|
|
62.
|
2022/10/23
|
|
Addison's disease triggered by infection with mycobacterium abscessus, but not by adrenal tuberculosis or MAC pulmonary disease, in a subject with type 2 diabetes mellitus: case report
|
|
63.
|
2022/10/21
|
|
Usefulness of cortisol/ACTH ratio (CAR) for diagnosis of cushing's syndrome: comparison of CAR with findings in dexamethasone suppression test
|
|
64.
|
2022/10/13
|
|
Association between changes in pancreatic morphology and vascular complications in subjects with type 2 diabetes mellitus: a retrospective study
|
|
65.
|
2022/09/17
|
|
Sudden extensive bloody pleural and pericardial effusion in a subject with untreated known hypothyroidism after total thyroidectomy, triggered by pneumonia
|
|
66.
|
2022/08/02
|
|
Imeglimin exerts favorable effects on pancreatic β-cells by improving morphology in mitochondria and increasing the number of insulin granules
|
|
67.
|
2022/05/12
|
|
Effect of hyperglycemia-related acute metabolic disturbance on thyroid function parameters in adults.
|
|
68.
|
2022/04
|
|
Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
|
|
69.
|
2022/03/15
|
|
A case of prominent and persistent hypoglycemia by massive dose administration of long-acting insulin degludec: A possible pitfall in diabetes care.
|
|
70.
|
2022/03
|
|
Molecular Mechanism of Pancreatic β-Cell Failure in Type 2 Diabetes Mellitus
|
|
71.
|
2022/01
|
|
Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case report
|
|
72.
|
2022/01
|
|
Vitamin D deficiency osteomalacia triggered by long-term social withdrawal and unbalanced diet in a Japanese middle-aged subject: A case report
|
|
73.
|
2021/12
|
|
Association between Grit Scales and adherence to regular hospital visits among Japanese patients with type 2 diabetes: Prospective observational study
|
|
74.
|
2021/12
|
|
Efficacy and safety of adding ipragliflozin to insulin in Japanese patients with type 1 diabetes mellitus: a retrospective study
|
|
75.
|
2021/12
|
|
Syndrome of inappropriate secretion of thyroid-stimulating hormone in a subject with galactorrhea and menstrual disorder and undergoing infertility treatment
|
|
76.
|
2021/10
|
|
Acute necrotic esophagitis accompanied by hyperglycemic hyperosmolar syndrome in a subject with type 2 diabetes mellitus.
|
|
77.
|
2021/10
|
|
Amelioration of hypercalcemia by cinacalcet treatment in a subject with relapsing acquired hypocalciuric hypercalcemia: A case report
|
|
78.
|
2021/10
|
|
Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency
|
|
79.
|
2021/09
|
|
Effects of sedentary behavior and daily walking steps on body mass index and body composition: Prospective observational study using outpatient clinical data of Japanese patients with type2 diabetes
|
|
80.
|
2021/09
|
|
Idiopathic bilateral extraocular myositis in a subject with poorly controlled type 2 diabetes mellitus:Case report
|
|
81.
|
2021/08/12
|
|
Concurrence of overt Cushing’s syndrome and primary aldosteronism accompanied by aldosterone-producing cell cluster in adjacent adrenal cortex: case report
|
|
82.
|
2021/08/12
|
|
Multiple endocrine neoplasia type 1 with a frameshift mutation in its gene accompanied by a giant cervical lipoma and multiple fatty deposits in the pancreas: case report
|
|
83.
|
2021/08
|
|
Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice
|
|
84.
|
2021/08
|
|
Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study
|
|
85.
|
2021/07
|
|
Clinical characteristics of withdrawal of basal insulin therapy among Japanese patients with type 2 diabetes: A multicenter retrospective observational study.
|
|
86.
|
2021/07
|
|
Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine
|
|
87.
|
2021/06/25
|
|
Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy
|
|
88.
|
2021/06/09
|
|
A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time
|
|
89.
|
2021/06
|
|
Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy
|
|
90.
|
2021/03/22
|
|
Case Report: A Case of Pituitary Adenoma Producing Growth Hormone and Thyroid-Stimulating Hormone Simultaneously
|
|
91.
|
2021/03/17
|
|
Unexpected Pleiotropic Effects of SGLT2 Inhibitors: Pearls and Pitfalls of This Novel Antidiabetic Class
|
|
92.
|
2021/03/05
|
|
Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History
|
|
93.
|
2021/01/14
|
|
Dulaglutide exerts beneficial anti atherosclerotic effects in ApoE knockout mice with diabetes: the earlier, the better
|
|
94.
|
2020/12/11
|
|
Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling
|
|
95.
|
2020/11/20
|
|
Comparison in effects by three kinds of glucose-lowering drugs on nonalcoholic fatty liver disease in cases with type 2 diabetes: A randomized, open-label, 3-arm active-control study.
|
|
96.
|
2020/08
|
|
Insulin allergy brought out 8 years after starting insulin therapy in a subject with type 1 diabetes mellitus
|
|
97.
|
2020/05/15
|
|
Association Between Severity of Diabetic Neuropathy and Success in Weight Loss During Hospitalization Among Japanese Patients with Type 2 Diabetes: A Retrospective Observational Study.
|
|
98.
|
2020/05
|
|
Impact of physical activity and sedentary time on glycated hemoglobin levels and body composition: Cross- sectional study using outpatient clinical data of Japanese patients with type 2 diabetes.
|
|
99.
|
2020/04/02
|
|
Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus: A Retrospective Study.
|
|
100.
|
2019/09
|
|
Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: A retrospective longitudinal study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus
|
|
101.
|
2019/07
|
|
Vascular endothelial PDPK1 plays a pivotal role in the maintenance of pancreatic beta cell mass and function in adult male mice
|
|
102.
|
2019/04
|
|
Idiopathic and isolated adrenocorticotropic hormone deficiency presenting as continuous epigastric discomfort without symptoms of hypoglycemia: a case report.
|
|
103.
|
2019/03
|
|
Verification of Kumamoto Declaration 2013 and Glycemic Targets for Elderly Patients with Diabetes in Japan for prevention of diabetic complications: A retrospective longitudinal study using outpatient clinical data.
|
|
104.
|
2019/01
|
|
Effect of mild exercise on glycemic and bodyweight control in Japanese type 2 diabetes patients: A retrospective analysis.
|
|
105.
|
2019/01
|
|
Effect of mild exercise on glycemic and bodyweight control in Japanese type 2 diabetes patients: A retrospective analysis.
|
|
106.
|
2019/01
|
|
Eicosapentaenoic acid/arachidonic acid ratio and weight loss during hospitalization for glycemic control among overweight Japanese patients with type 2 diabetes: a retrospective observational study.
|
|
107.
|
2019/01
|
|
Suppression of free fatty acid receptor 1 expression in pancreatic beta-cells in obese type 2 diabetic db/db mice: a potential role of pancreatic and duodenal homeobox factor 1
|
|
108.
|
2018/11
|
|
Administration of RAS Inhibitor before the Onset of Diabetic Nephropathy Counteracts the Adverse Effect of Chronic Hyperglycemia and Reduces the Augmentation of Urinary Albumin Excretion: A Retrospective Clinical Study
|
|
109.
|
2018/10
|
|
Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic beta-cells in db/db mice: The earlier and longer, the better.
|
|
110.
|
2018/08
|
|
Down-regulation of vascular GLP-1 receptor expression in human subjects with obesity
|
|
111.
|
2018/08
|
|
There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study.
|
|
112.
|
2018/06
|
|
Durability of protective effect of dulaglutide on pancreatic beta -cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure.
|
|
113.
|
2018/06
|
|
Onset of type 1 diabetes mellitus and heparin-induced thrombocytopenia in a patient with Basedow's disease and idiopathic thrombocytopenic purpura: Novel combination as autoimmune polyglandular syndrome.
|
|
114.
|
2018/06
|
|
Switching from low-dose thiazide diuretics to sodium-glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension.
|
|
115.
|
2018/05
|
|
Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis.
|
|
116.
|
2018/02
|
|
Pancreatic alpha cells in diabetic rats express active GLP-1 receptor: Endosomal co-localization of GLP-1/GLP-1R complex functioning through intra-islet paracrine mechanism
|
|
117.
|
2018/01
|
|
Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus.
|
|
118.
|
2018
|
|
Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis
|
|
119.
|
2017/11
|
|
Decreased GLP-1 receptor expression in endothelial and smooth muscle cells in diabetic db/db mice.
|
|
120.
|
2017/09
|
|
Increase of cortisol / ACTH ratio after chronic treatment with liraglutide in subjects with type 2 diabetes mellitus.
|
|
121.
|
2017/08
|
|
Werner Syndrome and Diabetes Mellitus Accompanied by Adrenal Cortex Cancer.
|
|
122.
|
2017/06
|
|
Hypoglycemic Coma Induced by the Use of Succinic Acid Cibenzoline in Frail Late-stage Elderly Subjects.
|
|
123.
|
2017/05
|
|
Advanced breast cancer in a relatively young man with severe obesity and type 2 diabetes mellitus.
|
|
124.
|
2017/05
|
|
Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes Mellitus.
|
|
125.
|
2017/03
|
|
Beneficial effects of SGLT2 inhibitors for preservation of pancreatic B-cell function and reduction of insulin resistance.
|
|
126.
|
2017/03
|
|
Temporal lobe epilepsy associated with GAD autoimmunity.
|
|
127.
|
2017/02
|
|
The presence of dementia as one of diabetic complications: Hyperglycemia, hypoglycemia and glycemic fluctuation are associated with the development of dementia.
|
|
128.
|
2016/11
|
|
Association of GA/HbA1c ratio and cognitive impairment in subjects with type 2 diabetes mellitus.
|
|
129.
|
2016/11
|
|
Dramatic mitigation of bone pain after phosphorus replacement therapy in a subject with FGF23-related hypophosphatemic osteomalacia
|
|
130.
|
2016/11
|
|
Human serum albumin: Possible cause of insulin autoimmune syndrome.
|
|
131.
|
2016/09
|
|
Controversy about the relationship between sulfonylurea use and cardiovascular events and mortality.
|
|
132.
|
2016/09
|
|
Strawberry milk-like blood in a subject with diabetic lipemia: dramatic change to transparent color after insulin therapy.
|
|
133.
|
2016/08
|
|
Clinical effects of liraglutide are possibly influenced by hypertriglyceridemia and remaining pancreatic beta-cell function in subjects with type 2 diabetes mellitus.
|
|
134.
|
2016/07
|
|
Case of disseminated pyomyositis in poorly controlled type 2 diabetes mellitus with diabetic ketoacidosis.
|
|
135.
|
2016/06
|
|
Hamman's syndrome triggered by the onset of type 1 diabetes mellitus accompanied by diabetic ketoacidosis.
|
|
136.
|
2016/06
|
|
Promising Diabetes Therapy Based on the Molecular Mechanism for Glucose Toxicity: Usefulness of SGLT2 Inhibitors As Well As Incretin-Related Drugs.
|
|
137.
|
2016/05
|
|
Case of iliopsoas abscess that was markedly recovered after percutaneous and surgical drainage in a patient with poorly controlled type 2 diabetes.
|
|
138.
|
2016/03
|
|
Appropriate therapy for type 2 diabetes mellitus in view of pancreatic B-cell glucose toxicity: the earlier
|
|
139.
|
2016/03
|
|
Influence of atherosclerosis-related risk factors on serum hs-CRP levels in type 2 diabetic patients: Comparison of their influence between in obese and non-obese subjects.
|
|
140.
|
2016/02
|
|
Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic B-cells in obese type 2 diabetic db/db mice.
|
|
141.
|
2016/01
|
|
Ice cube tray-shaped insulin lipoatrophy throughout the abdomen in a subject with type 2 diabetes.
|
|
142.
|
2016
|
|
Appropriate therapy for type 2 diabetes mellitus in view of pancreatic β-cell glucose toxicity: "the earlier, the better"
|
|
143.
|
2016
|
|
Seven-year Observational Study on the Association between Glycemic Control and the New Onset of Macroangiopathy in Japanese Subjects with Type 2 Diabetes
|
|
144.
|
2015/09
|
|
Combination of DPP-4 inhibitor and PPARr agonist exerts protective effects on pancreatic beta-cells in diabetic db/db mice through the augmentation of IRS-2 expression.
|
|
145.
|
2015/09
|
|
Pancreatic Inflammation Captured by Imaging Technology at the Onset of Fulminant Type 1 Diabetes.
|
|
146.
|
2015/08
|
|
Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)
|
|
147.
|
2015/07
|
|
Pseudoaldosteronism induced by Yokukansan in an elderly Japanese type 2 diabetes mellitus patient with Alzheimer's disease.
|
|
148.
|
2015/06
|
|
Anti-hypertensive azelnidipine preserves insulin signaling and glucose uptake against oxidative stress in 3T3-L1 adipocytes
|
|
149.
|
2015/06
|
|
Low bilirubin levels are an independent risk factor for diabetic retinopathy and nephropathy in Japanese patients with type 2 diabetes.
|
|
150.
|
2015/05
|
|
Case of newly onset type 1 diabetes after highly active antiretroviral therapy against HIV infection.
|
|
151.
|
2015/05
|
|
Rapid onset of syndrome of inappropriate antidiuretic hormone secretion induced by duloxetine in an elderly type 2 diabetic patient with painful diabetic neuropathy.
|
|
152.
|
2015/01
|
|
Protective effects of pioglitazone and/or liraglutide on pancreatic B-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes
|
|
153.
|
2015
|
|
A case of disseminated pyomyositis in poorly controlled type 2 diabetes with diabetic ketoacidosis.
|
|
154.
|
2015
|
|
Case of iliopsoas abscess which was markedly recovered after percutaneous and surgical drainage in a subject with poorly controlled type 2 diabetes.
|
|
155.
|
2015
|
|
Dietary restriction preserves the mass and function of pancreatic β cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic mice
|
|
156.
|
2013/05
|
|
Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus.
|
|
157.
|
2013/02
|
|
Vildagliptin preserves the mass and function of pancreatic cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
|
|
158.
|
2012/02
|
|
Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival.
|
|
159.
|
2011/05
|
|
The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
|
|
160.
|
2009/09
|
|
Gallbladder edema in type 1 diabetic patient due to delayed-type insulin allergy.
|
|
161.
|
2009/09
|
|
Gallbladder edema in type 1 diabetic patient due to delayed-type insulin allergy.
|
|
162.
|
2009/08
|
|
Molecular Analysis of db Gene-related Pancreatic beta Cell Dysfunction; Evidence for a Compensatory Mechanism Inhibiting Development of Diabetes in the db Gene Heterozygote.
|
|
163.
|
2009/08
|
|
Molecular Analysis of db Gene-related Pancreatic beta Cell Dysfunction; Evidence for a Compensatory Mechanism Inhibiting Development of Diabetes in the db Gene Heterozygote.
|
|
164.
|
2007/08
|
|
Pharmacokinetics and pharmacodynamics of glimepiride in type 2 diabetic patients: compared effects of once- versus twice-daily dosing.
|
|
165.
|
2007/08
|
|
Pharmacokinetics and pharmacodynamics of glimepiride in type 2 diabetic patients: compared effects of once- versus twice-daily dosing.
|
|
Display 5 items
|
|
Display all(165)
|
